Why is Philip Morris International Inc. stock rising?
ZYN portfolio expansion in the U.S. adds new strengths and formats in Q3 2026.
New U.S. ZYN capacity in Colorado is ramping into full-scale commercial production, supporting future variant launches and U.S. growth.
PMI is preparing for a future U.S. launch of IQOS ILUMA, subject to FDA action.
VEEV One Plus device technology is being progressively rolled out to strengthen PMI's international e-vapor franchise.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Philip Morris International Inc. and 4,900+ companies.